Sakura and MEDIPATH Transform Pathology

Sakura Finetek Europe and MEDIPATH have joined forces to enhance cancer diagnostics through the deployment of Tissue-Tek AutoTEC® a120 automated embedding systems across multiple pathology centers in France. This collaboration supports MEDIPATH’s commitment to delivering high-quality, timely cancer diagnostics, addressing the growing demand fueled by rising cancer cases. The advanced systems enable automated, standardized embedding, crucial for maintaining diagnostic precision and ensuring efficient workflow.

MEDIPATH processes over 1.5 million cases annually, including 140,000 cancer diagnoses. With Sakura’s expertise, the implementation has optimized workflows and trained technicians, ensuring that the technology delivers its maximum potential. The Tissue-Tek AutoTEC a120’s innovative design preserves sample integrity and enables precise traceability, ensuring reliability in diagnostics while supporting lean management practices in pathology.